BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Naphazoline

An adrenergic vasoconstrictor agent used as a decongestant.

298+ PubMed studies analyzed · 19 RCTs · Evidence Score: 42.4

Research Domains

Naphazoline has been studied across 16 research domains including 🧠 Focus & Attention, ❤️ Cardiovascular, 🫁 Respiratory, 🫘 Kidney, 😴 Sleep. The primary research focus is 🧠 Focus & Attention with 11% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Naphazoline, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

rauwolscine
7 shared targets
brimonidine
6 shared targets
corynantheine
6 shared targets
Piperoxan
6 shared targets
Methoxamine
6 shared targets
cirazoline
5 shared targets
dexniguldipine
6 shared targets
terazosin
6 shared targets
Tolazoline
6 shared targets
Indoramin
6 shared targets
Loading evidence profile...

This evidence profile for Naphazoline is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.